SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 1 filers reported holding SIO GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $215,000 | -76.5% | 166,806 | -60.5% | 0.03% | -71.0% |
Q3 2021 | $916,000 | -7.8% | 422,148 | +16.0% | 0.09% | -17.0% |
Q2 2021 | $993,000 | +158.6% | 363,887 | +147.6% | 0.11% | +75.0% |
Q1 2021 | $384,000 | -61.0% | 146,968 | -58.5% | 0.06% | -60.2% |
Q4 2020 | $985,000 | – | 354,265 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sassicaia Capital Advisers LLC | 310,500 | $863,000 | 1.79% |
Consonance Capital Management LP | 3,186,335 | $8,858,000 | 0.83% |
Opaleye Management Inc. | 2,000,000 | $5,560,000 | 0.73% |
Sio Capital Management, LLC | 886,665 | $2,465,000 | 0.50% |
Rubric Capital Management LP | 2,335,200 | $6,492,000 | 0.48% |
Affinity Asset Advisors, LLC | 250,000 | $695,000 | 0.37% |
GSA CAPITAL PARTNERS LLP | 354,265 | $985,000 | 0.16% |
Hudson Bay Capital Management LP | 3,200,000 | $8,896,000 | 0.05% |
Insight Advisors, LLC/ PA | 24,000 | $67,000 | 0.02% |
Maven Securities LTD | 86,788 | $246,000 | 0.02% |